semaglutide microdosing Microdose Does Microdosing Ozempic Work? Know

Book your session now and embrace a revitalized, glowing you

The pharmaceutical versions, semaglutide and tirzepatide , are significantly more potent and longer-lasting than the natural hormone

Zepbound (tirzepatide) is a once-weekly subcutaneous injection approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition

doi: 10.3389/fgstr.2026.1790420 Received 18 January 2026 Revised 18 April 2026 Accepted 27 April 2026 Published 18 May 2026 Volume 5 - 2026 Edited by Glen A

Rotating injection sites prevents the development of localized tissue irritation or lipodystrophy (changes in subcutaneous fat)

Comprehensive Medical Screening: Clinicians should evaluate for: Thyroid nodules or goiter : Baseline neck examination and review of recent thyroid ultrasound if clinically indicated Personal or family history of thyroid cancer : Particularly medullary thyroid carcinoma Comorbid conditions : Type 2 diabetes, cardiovascular disease, pancreatitis history Gastrointestinal disorders : Severe gastroparesis (potential contraindication) Renal function : Use caution in patients at risk for volume depletion/renal impairment Psychiatric conditions : Depression, eating disorders Pregnancy status : These medications are not recommended during pregnancy and should be discontinued when pregnancy is recognized Laboratory Assessment: Baseline testing should include: TSH and free T4 Comprehensive metabolic panel (renal and hepatic function) Lipid panel Hemoglobin A1c (if diabetic or prediabetic) Routine calcitonin screening or thyroid ultrasound is not recommended solely for GLP-1 therapy initiation